Herbals Should Be Subject To Same Standards As Drugs – JAMA Article
This article was originally published in The Tan Sheet
Executive Summary
Herbal products should be subject to the same premarket evaluation of safety and efficacy as drugs, the head of NCCAM and other NIH leaders argue in an article on ethical issues in complementary and alternative medicine research
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning